We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for real-time alerts, custom portfolio, and market movers
The current HALO market cap is 4.96B. The company's latest EPS is USD 2.2203 and P/E is 17.62.
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 208.98M | 181.5M | 162.14M | 221.04M | 216.03M |
| Operating Income | 63.19M | 74.51M | 53.8M | 94.46M | 88.28M |
| Net Income | 61.63M | 57.7M | 39.62M | 74.75M | 81.84M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 195.99M | 267.59M | 443.31M | 660.12M | 829.25M |
| Operating Income | -67.61M | 144.26M | 275.9M | 267.53M | 337.57M |
| Net Income | -72.24M | 129.09M | 402.71M | 202.13M | 281.59M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 1.86B | 1.84B | 1.7B | 1.81B | 1.89B |
| Total Liabilities | 1.77B | 1.67B | 1.63B | 1.66B | 1.64B |
| Total Equity | 96.99M | 169.8M | 65.85M | 151.03M | 249.18M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 565.87M | 579.92M | 1.1B | 1.84B | 1.73B |
| Total Liabilities | 474.11M | 428.88M | 907.48M | 1.67B | 1.65B |
| Total Equity | 91.77M | 151.05M | 196.95M | 169.8M | 83.81M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | 157.66M | 240.11M | 86.96M | 153.81M | 286.22M |
| Investing | -485.26M | -487.01M | -60.16M | -5.17M | -88.62M |
| Financing | 356.04M | 362.37M | -164.61M | -162.17M | -158.07M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -85.42M | 55.45M | 299.44M | 240.11M | 388.57M |
| Investing | -5.55M | 78.35M | -406.29M | -487.01M | -96.91M |
| Financing | 153.22M | -106.28M | 77.87M | 362.37M | -407.99M |
| Market Cap | 4.96B |
| Price to Earnings Ratio | 17.62 |
| Price to Sales Ratio | 5.98 |
| Price to Cash Ratio | 41.92 |
| Price to Book Ratio | 59.2 |
| Dividend Yield | - |
| Shares Outstanding | 126.82M |
| Average Volume (1 week) | 773.68k |
| Average Volume (1 Month) | 876.74k |
| 52 Week Change | 14.15% |
| 52 Week High | 45.00 |
| 52 Week Low | 29.85 |
| Spread (Intraday) | 1.19 (2.98%) |
| Company Name | Halozyme Therapeutics Incorporated |
| Address |
1209 orange street wilmington, delaware 19801 |
| Website | https://www.halozyme.com |
| Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
